Sartorius has entered into a global sales partnership with BlueSens for marketing and distribution of oxygen and carbon dioxide sensors.
In recent years, Sartorius has expanded its process analytics portfolio in the area of sensor technology in order to measure critical process parameters, such as pH and dissolved oxygen, temperature, glucose, lactate and biomass, non-invasively and in real time.
The latest oxygen and carbon dioxide sensors are further important additions to the Sartorius range of analytical products.
BioPAT Xgas enables precise, reproducible information to be obtained about the progress of fermentation, without having to take samples and analyse them off-line in a laboratory.
Stefan Schlack, senior vice president of marketing at Sartorius, said: “These sensors make our bioreactors even more intelligent. They analyse metabolic processes in real time during cultivation and help our customers better understand their processes. Used in combination with our software, these sensors are powerful tools for optimising biopharmaceutical production processes and accelerating development.”
Dr. Holger Müller, aales and marketing manager at BlueSens, added: “In fermentation, Sartorius Stedim Biotech is among the leading suppliers worldwide and has a strong, global sales network. We would like to leverage these advantages in order to reach considerably more customers. I am looking forward to our partnership.”
BioPAT Xgas will be sold as an equipment package that includes the Sartorius single-use and reusable bioreactors.
Ready to use out of the box, the sensors are completely integrated into Sartorius’s BioPAT DCU control units and SCADA software, called BioPAT MFCS.
In conjunction with Sartorius software, BioPAT Xgas analyses critical process variables, such as oxygen uptake rate (OUR), carbon dioxide production rate (CPR) or respiratory quotient (RQ).